$193.01 $0.95 (0.5%)

04:00 PM EDT on 08/16/19

ABIOMED, Inc. (NASDAQ:ABMD)

CAPS Rating: 4 out of 5

The Company is a provider of medical devices in circulatory support and offer a continuum of care in heart recovery to acute heart failure patients.

Current Price $193.01 Mkt Cap $9.1B
Open $192.64 P/E Ratio 0.00
Prev. Close $192.06 Div. (Yield) $0.00 (0.0%)
Daily Range $191.84 - $194.47 Volume 484,436
52-Wk Range $181.02 - $364.31 Avg. Daily Vol. 13

Caps

How do you think NASDAQ:ABMD will perform against the market?

Add Stock to CAPS Watchlist

All Players

337 Outperform
39 Underperform
 

All-Star Players

110 Outperform
15 Underperform
 

Wall Street

7 Outperform
4 Underperform
 

Top NASDAQ:ABMD Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

TMFPencils (99.87)
Submitted August 09, 2019

Despite what appear to be shorter-term headwinds, Abiomed continues to pump out cash and maintain a sterling balance sheet. The valuation is at levels not seen much (if at all) over the past five years. The company's "issues" seem correctable to me,… More

ScreenerStizBear (42.74)
Submitted June 26, 2008

I simply used the screener to identify 1-star companies with the highest 52-week gain. The 1-star rating should mean they are bad companies and the 52-week gain should mean they are overpriced. We’ll see how it works!

NASDAQ:ABMD VS S&P 500 (SPY)

Fools bullish on NASDAQ:ABMD are also bullish on:

Recent Community Commentary

Read the most recent pitches from players about ABMD.

Recs

0
Member Avatar OklaBoston (< 20) Submitted: 8/9/2019 2:56:52 PM : Underperform Start Price: $191.53 NASDAQ:ABMD Score: -1.85

Downtrended and still well above the $52.00 I would willingly pay for it.

Recs

1
Member Avatar TMFPencils (99.87) Submitted: 8/9/2019 1:48:40 PM : Outperform Start Price: $191.32 NASDAQ:ABMD Score: +2.01

Despite what appear to be shorter-term headwinds, Abiomed continues to pump out cash and maintain a sterling balance sheet. The valuation is at levels not seen much (if at all) over the past five years. The company's "issues" seem correctable to me, given its dominant financial position and lack of any meaningful competition. Gonna start this out on CAPS and see how it goes. :-) Outperform.

Recs

0
Member Avatar fadeoutandroid (< 20) Submitted: 7/13/2019 4:30:23 AM : Outperform Start Price: $259.93 NASDAQ:ABMD Score: -21.82

Abiomed makes the Impella heart pump, which is a breakthrough design in pumps and adoption in the US and abroad will rise over the next years.

Leaderboard

Find the members with the highest scoring picks in ABMD.

Score Leader

ClaytonHP

ClaytonHP (< 20) Score: +3,205.49

The Score Leader is the player with the highest score across all their picks in ABMD.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
ClaytonHP < 20 3/27/2009 Outperform 3M $5.42 +3,461.07% +255.58% +3,205.49 0 Comment
NoWhereToGoButUp 79.67 3/25/2009 Outperform NS $5.44 +3,447.98% +266.16% +3,181.81 0 Comment
Dennyf10 53.03 6/3/2009 Outperform 1Y $6.44 +2,897.05% +213.70% +2,683.35 0 Comment
TSStechtrader 38.65 8/11/2009 Outperform NS $7.31 +2,540.36% +188.56% +2,351.80 0 Comment
dteasley4 90.71 6/8/2009 Outperform 3Y $7.30 +2,543.97% +210.91% +2,333.07 0 Comment
YahooSIRIous 77.04 7/13/2009 Outperform 5Y $7.93 +2,333.92% +228.54% +2,105.38 0 Comment
This player feels very strongly about this pick and has marked it a Top Pick. Top Picks do not affect a player’s score. henrik1123 < 20 1/8/2010 Outperform 5Y $8.21 +2,250.03% +152.89% +2,097.14 0 Comment
QuickStoch 94.67 7/15/2009 Outperform 3W $8.06 +2,294.67% +212.86% +2,081.80 0 Comment
PitBullCapital < 20 1/11/2010 Outperform 5Y $8.29 +2,228.23% +150.91% +2,077.31 0 Comment
ezdoggy 65.16 12/29/2009 Outperform 5Y $8.80 +2,093.30% +155.51% +1,937.79 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

Player Name Player
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
S&P
Gain
Score End Date Commentary
TrackJimCramer 86.43 1/27/2016 Underperform 3W $83.35 +131.57% +53.48% -78.08 0 Comment
TrackTheBenchmar 83.46 10/1/2013 Outperform NS $19.40 +894.90% +71.73% +823.17 0 Comment
TrackZacks < 20 11/2/2012 Underperform 3M $13.86 -2.24% -2.29% -0.05 11/12/2012 @ $13.55 1 Comment
TrackZacks < 20 7/11/2012 Outperform 3M $23.91 -6.61% +5.22% -11.83 8/31/2012 @ $22.33 1 Comment
TrackCitigroup 85.70 6/15/2012 Outperform NS $21.44 +800.23% +116.49% +683.75 0 Comment
TrackJimCramer 86.43 2/7/2012 Outperform 3W $22.70 +267.18% +39.57% +227.61 1/27/2016 @ $83.35 0 Comment
TrackRodmanRen < 20 12/19/2011 Underperform NS $18.36 +951.25% +136.56% -814.69 0 Comment
TrackZacks < 20 11/11/2011 Outperform 3M $19.41 +14.12% +5.91% +8.21 6/15/2012 @ $22.15 1 Comment
TrackRWBaird 88.13 4/29/2011 Outperform NS $17.16 +1,024.77% +112.07% +912.70 0 Comment
TrackWunderlich < 20 12/9/2010 Outperform NS $9.41 +1,951.12% +132.92% +1,818.20 0 Comment
TrackRodmanRen < 20 12/8/2010 Underperform NS $9.67 +26.78% -2.73% -29.52 8/15/2011 @ $12.26 0 Comment
TrackWedbush 88.42 5/11/2010 Outperform NS $9.20 +1,997.93% +150.93% +1,847.00 0 Comment
TrackUBS 91.68 10/31/2009 Underperform NS $9.19 +2,000.22% +171.64% -1,828.58 0 Comment
TrackPiperJaff 84.76 4/9/2009 Outperform NS $5.40 +204.07% +84.55% +119.52 4/9/2013 @ $16.42 0 Comment
TrackUBS 91.68 3/25/2009 Outperform NS $5.95 +54.45% +30.72% +23.74 10/30/2009 @ $9.19 0 Comment
TrackSMHCapital 42.97 7/29/2008 Underperform NS $18.80 +926.65% +138.02% -788.63 0 Comment
TrackLehmanBros < 20 12/20/2007 Outperform NS $15.00 +38.00% -5.97% +43.97 4/17/2012 @ $20.70 0 Comment
TrackUBS 91.68 12/7/2007 Outperform NS $13.67 -30.43% -43.26% +12.83 2/6/2009 @ $9.51 0 Comment
TrackStifel 91.45 11/9/2006 Outperform NS $13.55 +1,324.43% +120.44% +1,203.98 0 Comment
TrackLazardCapit 36.94 9/7/2006 Outperform NS $14.88 +1,197.11% +136.72% +1,060.39 0 Comment
TrackJimCramer 86.43 9/5/2006 Underperform 3W $14.98 +51.54% +2.31% -49.22 2/8/2012 @ $22.70 0 Comment